- Home
- APVO vs IMTE Comparison
APVO vs IMTE Comparison
Compare APVO & IMTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- IMTE
- Stock Information
- Founded
- APVO 2016
- IMTE 2008
- Country
- APVO United States
- IMTE Malaysia
- Employees
- APVO N/A
- IMTE N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- IMTE Consumer Electronics/Appliances
- Sector
- APVO Health Care
- IMTE Consumer Staples
- Exchange
- APVO Nasdaq
- IMTE Nasdaq
- Market Cap
- APVO 4.1M
- IMTE 4.1M
- IPO Year
- APVO N/A
- IMTE N/A
- Fundamental
- Price
- APVO $4.95
- IMTE $1.12
- Analyst Decision
- APVO Strong Buy
- IMTE
- Analyst Count
- APVO 1
- IMTE 0
- Target Price
- APVO $5,920.00
- IMTE N/A
- AVG Volume (30 Days)
- APVO 393.8K
- IMTE 9.9K
- Earning Date
- APVO 05-14-2025
- IMTE 06-17-2025
- Dividend Yield
- APVO N/A
- IMTE N/A
- EPS Growth
- APVO N/A
- IMTE N/A
- EPS
- APVO N/A
- IMTE N/A
- Revenue
- APVO N/A
- IMTE $123,337.00
- Revenue This Year
- APVO N/A
- IMTE N/A
- Revenue Next Year
- APVO N/A
- IMTE N/A
- P/E Ratio
- APVO N/A
- IMTE N/A
- Revenue Growth
- APVO N/A
- IMTE 4.75
- 52 Week Low
- APVO $4.30
- IMTE $0.51
- 52 Week High
- APVO $658.60
- IMTE $3.17
- Technical
- Relative Strength Index (RSI)
- APVO 28.32
- IMTE 41.83
- Support Level
- APVO $4.30
- IMTE $1.05
- Resistance Level
- APVO $5.18
- IMTE $1.13
- Average True Range (ATR)
- APVO 1.22
- IMTE 0.04
- MACD
- APVO 0.72
- IMTE -0.00
- Stochastic Oscillator
- APVO 6.47
- IMTE 35.00
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.